Successful management of MRSA sepsis in a patient with left ventricular assist device.
Left ventricular assist devices (LVADs) offer the opportunity to substantially improve the clinical conditions and to interrupt hospitalization of patients suffering from end-stage heart failure awaiting heart transplantation. The authors report a case of a 66-year old patient suffering from end-stage idiopathic dilative cardiomyopathy who needed the implantation of a LVAD and later developed a sepsis with a methicillin resistant Staphylococcus aureus (MRSA) which could be recovered by a differentiated antibiotic regimen.
Alejnik
I
I
Department of Thoracic and Cardiovascular Surgery, Hospital of the University of Münster, Münster, Germany. sinderm@uni-muenster.de
Hoffmann
J
J
Scheld
H H
HH
Vahlhaus
C
C
Klotz
S
S
Hoffmeier
A
A
Schmidt
C
C
Sindermann
J R
JR
D000368:Aged; D006353:Heart-Assist Devices; D006801:Humans; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus; D011183:Postoperative Complications / Q000188:drug therapy* / Q000382:microbiology*; D012074:Remission Induction; D013203:Staphylococcal Infections / Q000188:drug therapy*